Feb 28, 2024 9:00am EST IMC Announces Potential Reverse Merger with Kadimastem a leading Clinical cell therapy company
Jan 31, 2024 7:00am EST IM Cannabis Receives 180 Calendar Day Extension from the Nasdaq Stock Market to Regain Compliance with Bid Price Rule